Terms: = Kidney tumors AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Prognosis
85 results:
1. Therapeutic strategies and predictive models for Xp11.2 translocation/tfe3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y; Zhao C; Wang Z; Liu F; Zhao M; Yang H; Chen J; Chen X; Shi M; Jiang D; Luo X; Duan Y; Bai Y
Aging (Albany NY); 2024 Jan; 16(2):1696-1711. PubMed ID: 38261736
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-tfe3 rearranged renal cell carcinoma in an NAD
Chen Y; Lu Y; Yang L; Ma W; Dong Y; Zhou S; Liu N; Gan W; Li D
J Exp Clin Cancer Res; 2023 Sep; 42(1):252. PubMed ID: 37770905
[TBL] [Abstract] [Full Text] [Related]
3. Cystic MED15::tfe3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature.
Doytcheva K; Gallan AJ; Wang P; Wanjari P; Segal J; Antic T
Hum Pathol; 2023 Jun; 136():25-33. PubMed ID: 36997032
[TBL] [Abstract] [Full Text] [Related]
4. Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential.
Yang B; Sun L; Cao WF; Qi LS; Guo YH; Sun Y
Diagn Pathol; 2023 Feb; 18(1):27. PubMed ID: 36810118
[TBL] [Abstract] [Full Text] [Related]
5. A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features.
Wang X; Yu J; Fan X; Ma S; Xie X; Gao N; Huang S; Lu A
BMC Urol; 2023 Feb; 23(1):17. PubMed ID: 36782230
[TBL] [Abstract] [Full Text] [Related]
6. p53 aberration and tfe3 gene amplification may be predictors of adverse prognosis in epithelioid angiomyolipoma of the kidney.
Zhang Y; Wei X; Teng X; Chen G
Diagn Pathol; 2023 Feb; 18(1):14. PubMed ID: 36740682
[TBL] [Abstract] [Full Text] [Related]
7. tfe3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic study.
Takamatsu D; Kohashi K; Kiyozawa D; Kinoshita F; Ieiri K; Baba M; Eto M; Oda Y
Pathol Res Pract; 2023 Feb; 242():154313. PubMed ID: 36669395
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/tfe3 gene fusion renal cell carcinomas.
Zhou J; Zhao L; Yang Z; Chen Y; Wu X; Xue W
BMC Urol; 2022 Jul; 22(1):109. PubMed ID: 35850864
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of clinicopathological and molecular features of ELOC(TCEB1)-mutant renal cell carcinoma.
Wang Y; Zhao P; Wang L; Wang J; Ji X; Li Y; Shi H; Li Y; Zhang W; Jiang Y
Pathol Res Pract; 2022 Jul; 235():153960. PubMed ID: 35653922
[TBL] [Abstract] [Full Text] [Related]
10. [Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].
Zhang HZ; Xia QY; Yin XG; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):437-443. PubMed ID: 35511640
[No Abstract] [Full Text] [Related]
11. Integrated exome and RNA sequencing of tfe3-translocation renal cell carcinoma.
Sun G; Chen J; Liang J; Yin X; Zhang M; Yao J; He N; Armstrong CM; Zheng L; Zhang X; Zhu S; Sun X; Yang X; Zhao W; Liao B; Pan X; Nie L; Yang L; Chen Y; Zhao J; Zhang H; Dai J; Shen Y; Liu J; Huang R; Liu J; Wang Z; Ni Y; Wei Q; Li X; Zhou Q; Huang H; Liu Z; Shen P; Chen N; Zeng H
Nat Commun; 2021 Sep; 12(1):5262. PubMed ID: 34489456
[TBL] [Abstract] [Full Text] [Related]
12. Eosinophilic Solid and Cystic Renal Cell Carcinoma With Melanin Pigment-Expanding the Morphological Spectrum.
Aldera AP; Hes O
Int J Surg Pathol; 2022 May; 30(3):295-299. PubMed ID: 34402332
[TBL] [Abstract] [Full Text] [Related]
13. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
[TBL] [Abstract] [Full Text] [Related]
14. Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.
Wu Y; Chen S; Zhang M; Liu K; Jing J; Pan K; Zhang L; Xu B; Lu X; Chen M
Pathol Oncol Res; 2021; 27():610360. PubMed ID: 34257577
[No Abstract] [Full Text] [Related]
15. Multidrug refractory aggressive metastatic tfe3 (+) renal cell carcinoma: A case report.
Paksoy N; Erdem S; Karaca M; Ak N; Pehlivan M; Yirgin IK; Ozluk Y; Ekiz F; Tural D; Ekenel M; Ozcan F; Basaran M
J Oncol Pharm Pract; 2022 Jan; 28(1):215-221. PubMed ID: 34134568
[TBL] [Abstract] [Full Text] [Related]
16. [Metastatic renal cell carcinoma: a clinicopathological analysis of 196 cases].
Zhu Y; Han CH; Yang YL; Xu JJ; Yu YW
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1255-1260. PubMed ID: 33287509
[No Abstract] [Full Text] [Related]
17. Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
Ma W; Yang J; Liu N; Pu X; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Li D; Gan W
BMC Cancer; 2020 Dec; 20(1):1182. PubMed ID: 33267784
[TBL] [Abstract] [Full Text] [Related]
18. tfe3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma.
Guo X; Li R; Bai Q; Jiang S; Wang H
J Cell Mol Med; 2020 Dec; 24(24):14441-14452. PubMed ID: 33145941
[TBL] [Abstract] [Full Text] [Related]
19. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.
Wang Y; Wang Y; Feng M; Lian X; Lei Y; Zhou H
J Int Med Res; 2020 Oct; 48(10):300060520942095. PubMed ID: 33026261
[TBL] [Abstract] [Full Text] [Related]
20. The suitability of NONO-tfe3 dual-fusion FISH assay as a diagnostic tool for NONO-tfe3 renal cell carcinoma.
Liu N; Guo W; Shi Q; Zhuang W; Pu X; Chen S; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Gan W; Li D
Sci Rep; 2020 Oct; 10(1):16361. PubMed ID: 33004995
[TBL] [Abstract] [Full Text] [Related]
[Next]
